BioSpace News Archive

Madrigal Pharmaceuticals, Inc. reports first-quarter 2024 financial results and provides corporate updates.

Neumora Therapeutics, Inc. announced financial results for the first quarter ended March 31, 2024, and provided a business update.

BioCryst Pharmaceuticals, Inc. announced that the company will present at the following conferences.

uniQure N.V., a leading gene therapy company advancing transformative therapies for patients with severe medical needs, reported its financial results for the first quarter of 2024 and highlighted recent progress across its business.

Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system disorders, highlights oral and poster presentations on the Company’s preclinical gene therapy programs and vector engineering platform at the 27th ASGCT Annual Meeting being held May 7 – 11, 2024 in Baltimore, MD.

Diality Inc., a medical device company developing the Moda-flxTM Hemodialysis System, announced that Ravi Parthasarathy has joined the company as Chief Technology Officer.

Arbutus Biopharma Corporation announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences which are being held in New York.

Amolyt Pharma announced that the company has had multiple abstracts accepted for presentation at the 10th International Congress of the Growth Hormone Research Society, which is being held May 10-11 in Stockholm, Sweden, the 26th European Congress of Endocrinology, which is being held May 11-14 in Stockholm, Sweden, and at the 2024 Endocrine Society Meeting, which is being held June 1-4 in Boston, Massachusetts.